The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease.
about
MicroRNA-466 with tumor markers for cervical cancer screening.Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patientsTargeting the IL-6/JAK/STAT3 signalling axis in cancer.Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance.Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancerIdentifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
P2860
The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The assessment of the prognost ...... th early stage of the disease.
@en
type
label
The assessment of the prognost ...... th early stage of the disease.
@en
prefLabel
The assessment of the prognost ...... th early stage of the disease.
@en
P2093
P2860
P1433
P1476
The assessment of the prognost ...... ith early stage of the disease
@en
P2093
Beata Kotowicz
Malgorzata Fuksiewicz
Maria Kowalska
Mariusz Bidzinski
P2860
P2888
P304
P356
10.1007/S13277-015-3914-0
P577
2015-08-20T00:00:00Z